Registry study of adherence to treatment with rivaroxaban and warfarin in patients with atrial fibrillation, as requested by the Dental and Pharmaceutical Benefits Board (TLV)
This is a retrospective registry study to describe and compare the adherence among AF patients initiating treatment with rivaroxaban (without previous warfarin or NOAC use) with those initiating treatment with warfarin (with and without previous warfarin or NOAC use). It is a requirement by The Dental and Pharmaceutical Benefits Board (TLV) in Sweden to provide data on a comparison of adherence to NOAC treatment vs. warfarin for newly treated patients in atrial fibrillation. Several Swedish registries will be utilized.
No Inclusion Criteria Available
No Exclusion Criteria Available
Many locations, Sweden
E-mail: [email protected]
Phone: Not Available